The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Drug-Induced Parkinsonism Treated with Jodeung-san and Electro-acupuncture at GB34

조등산(Diaoteng-san, Choto-san, 釣藤散)과 GB34(陽陵泉) 전침치료를 활용한 약인성파킨슨증후군 환자의 증례 1례

  • Kim, Eun-ji (Dept. of Internal Korean Medicine, Dongshin Korean Medicine Hospital) ;
  • Song, Ho-joon (Dept. of Acupuncture & Moxibustion Medicine, Dongshin Korean Medicine Hospital) ;
  • Kim, Hyun-ho (Dept. of Acupuncture & Moxibustion Medicine, Dongshin Korean Medicine Hospital) ;
  • Han, Yang-hee (Dept. of Internal Korean Medicine, Dongshin Korean Medicine Hospital) ;
  • Leem, Jung-tae (Dept. of Internal Korean Medicine, Dongshin Korean Medicine Hospital)
  • 김은지 (목동동신한방병원 한방내과) ;
  • 송호준 (목동동신한방병원 침구과) ;
  • 김현호 (목동동신한방병원 침구과) ;
  • 한양희 (목동동신한방병원 한방내과) ;
  • 임정태 (목동동신한방병원 한방내과)
  • Received : 2017.09.08
  • Accepted : 2017.10.28
  • Published : 2017.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Drug-induced Parkinsonism is the most frequently observed type among the cases of secondary Parkinsonism. Besides typical parkinsonian symptoms, such as tremor, rigidity and bradykinesia, drug-induced Parkinsonism manifests with additional simultaneous symptoms like orobuccolingual dyskinesia, mixed type of tremor (resting, action), and symmetry of expressions. We present a case of drug-induced Parkinsonism, affected by taking the antiulcer drug cimetidine. Jodeung-san extract (Choto-san, Tsumura Co. 10) was administered for 7 days and acupuncture (electronic, auricular, pharmacopuncture) was conducted 3 times. The clinical outcomes were then evaluated through the patient's global impression of change, visual analogue scale, and Hoehn and Yahr stage. After the treatment, the clinical features, such as tremor and orobuccolingual dyskinesia, disappeared. The combination of Jodeung-san and electro-acupuncture at GB34 could therefore be a remedy for the patients with drug-induced Parkinsonism.

Keywords

References

  1. Grosset DG, Macphee GJA, Nairn M. GUIDELINES: Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ 2010;340(7739):206-9. https://doi.org/10.1136/bmj.c206
  2. Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson J, et al. Harrison's Principles of Internal Medicine. 19th Edition. New York: McGraw-Hill Prof. Publ.; 2015, p. 2609-26.
  3. Kim H, Kim GW, Koo BS. Clinical study on a case of a patient with a glossal tremor caused by a side effect of drugs. J Orient. Neuropsychiatry 2003;14(1):133-9.
  4. Lopez-Sendon J, Mena M, Garcia de Yebenes J. Drug-induced parkinsonism in the elderly: incidence, management and prevention. Drugs Aging 2012;29(2):105-18. https://doi.org/10.2165/11598540-000000000-00000
  5. Fann WE, Lake CR. Amantadine versus trihexyphenidyl in the treatment of neuroleptic-induced parkinsonism. Am J Psychiatry 1976;133(8):940-3. https://doi.org/10.1176/ajp.133.8.940
  6. Kim Y, Yang S, Kim J, Lee B, Cho S, Park S. Case of Drug-Induced Parkinsonism Treated with Traditional Korean Medicine. J Int Korean Med 2016;37(2):381-8.
  7. Jung SK, Song JM. Two Cases of Drug-induced Secondary Parkinsonism Treated with Sasang Constitutional Therapy. J Sasang Const Med 2012;24(4):109-19. https://doi.org/10.7730/JSCM.2012.24.4.109
  8. Shim YH, Park JY, Choi WW, Min IK, Park SU, Jung WS, et al. Herbal medicine treatment for drug-induced parkinsonism. J Altern Complement Med N Y N 2015;21(5):273-80. https://doi.org/10.1089/acm.2014.0124
  9. Michael EG, Daniel JC, Vibeke S, R. Michael G, Robert P. Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran. Int Assoc Study Pain 2010;149:373-8.
  10. Aicher B, Peil H, Peil B, Diener HC. Pain measurement: Visual Analogue Scale (VAS) and Verbal Rating Scale (VRS) in clinical trials with OTC analgesics in headache. Cephalalgia 2012;32(3):185-97. https://doi.org/10.1177/03331024111430856
  11. Goetz C, Poewe W, Rascol O, Sampaio C, Stebbins G, Counsell C. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19(9):1020-8. https://doi.org/10.1002/mds.20213
  12. Jeong BJ, Kim JW, Kim BC, Woo SH, Na YJ, Shim HJ, et al. A case of tremor in Parkinson's disease treated with Korean medicine. Korean J Orient Int Med 2006;27(4):954-60.
  13. Louis E. Essential tremor. N Engl J Med 2001;345:887-91. https://doi.org/10.1056/NEJMcp010928
  14. Anon. Health insurance statistic chronology in 2015. Health Insur. Rev. Serv. 2016. Available from: http://www.hira.or.kr/dummy.do?pgmid=HIRAA020045010000&cmsurl=/cms/medi_info/07/03/01/1351543_27398.html&subject=2015%eb%85%84+%ea%b1%b4%ea%b0%95%eb%b3%b4%ed%97%98%ed%86%b5%ea%b3%84%ec%97%b0%eb%b3%b4#none.
  15. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Mielke MM, Rocca WA. Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study. Mov Disord Off J Mov Disord Soc 2017;32(2):227-34. https://doi.org/10.1002/mds.26839
  16. Shuaib UA, Rajput AH, Robinson CA, Rajput A. Neuroleptic-induced Parkinsonism: Clinicopathological study. Mov Disord Off J Mov Disord Soc 2016;31(3):360-5. https://doi.org/10.1002/mds.26467
  17. Barbosa MT, Caramelli P, Maia DP, Cunningham MC, Guerra HL, Lima-Costa MF, et al. Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí study). Mov Disord 2006;21(6):800-8. https://doi.org/10.1002/mds.20806
  18. Montastruc JL, Llau ME, Rascol O, Senard JM. Drug-induced parkinsonism: a review. Fundam Clin Pharmacol 1994;8(4):293-306. https://doi.org/10.1111/j.1472-8206.1994.tb00808.x
  19. Lee AY, Mattew B, Howard IH. Parkinson's disease and Parkinsonian syndrome. Seoul: Koonja Publ.; 2000.
  20. Nguyen N, Pradel V, Micallef J, Montastruc JL, Blin O. Drug-induced parkinson syndromes. Therapie 2004;59(1):105-12. https://doi.org/10.2515/therapie:2004021
  21. Lopez-Sendon J, Mena M, Garcia de Yebenes J. Drug-induced parkinsonism. Expert Opin Drug Saf Inf Healthc 2013;12(4):487-96. https://doi.org/10.1517/14740338.2013.787065
  22. Kim SR, Lee TY, Kim MS, Lee MC, Chung SJ. Use of complementary and alternative medicine by Korean patients with Parkinson's disease. Clin Neurol Neurosurg 2009;111(2):156-60. https://doi.org/10.1016/j.clineuro.2008.09.011
  23. Ferry P, Johnson M, Wallis P. Use of complementary therapies and non-prescribed medication in patients with Parkinson's disease. Postgrad Med J 2002;78(924):612-4. https://doi.org/10.1136/pmj.78.924.612
  24. Shin HW, Kim MJ, Kim JS, Lee MC, Chung SJ. Levosulpiride-induced movement disorders. Mov Disord Off J Mov Disord Soc 2009;24(15):2249-53. https://doi.org/10.1002/mds.22805
  25. 洪元植校編. 精校黃帝內經素問. 東洋醫學硏究院 出版部; 1995, p. 23-5, 39-40.
  26. Jin JS, Kwon DY. A review on pharmacological properties of Jodeungsan. Korean J Orient Med Prescr 2008;16(1):55-64.
  27. Korean Acupuncture & Moxibustion Medicine Society Textbook publishing institute. The Acupuncture and Moxibustion. Vol. 2. Paju: Jipmoondang; 2008, p. 141.
  28. Imai H, Takeshima N, Oda H, Chen P, Sawada E, Furukawa TA. Choto-san versus placebo for patients with dementia: systematic review and meta-analysis. Psychogeriatr Off J Jpn Psychogeriatr Soc 2017.
  29. Yang Q, Goto H, Shimada Y, Kita T, Shibahara N, Terasawa K. Effects of Choto-san on hemorheological factors and vascular function in stroke-prone spontaneously hypertensive rats. Phytomedicine Int J Phytother Phytopharm 2002;9(2):93-8. https://doi.org/10.1078/0944-7113-00088
  30. Dohi K, Aruga T, Satoh K, Shioda S. Choto-san (Kampo Medicine) for the Treatment of Headache. Headache J Head Face Pain 2004;44(4):375.
  31. Ning Y, Li K, Fu C, Ren Y, Zhang Y, Liu H, et al. Enhanced Functional Connectivity between the Bilateral Primary Motor Cortices after Acupuncture at Yanglingquan (GB34) in Right-Hemispheric Subcortical Stroke Patients: A Resting-State fMRI Study. Front Hum Neurosci 2017;11:178.
  32. Liu L, Wu Y, Zheng J, Lai X, Zeng D, Li H, et al. Cerebral activation effects of acupuncture using Zusanli (ST36) and Yanglingquan (GB34) points based on Regional Homogeneity indices: A resting-state fMRI study. J X-Ray Sci Technol 2016;24(2):297-308. https://doi.org/10.3233/XST-160557
  33. Yeo S, Choe IH, van den Noort M, Bosch P, Jahng GH, Rosen B, et al. Acupuncture on GB34 activates the precentral gyrus and prefrontal cortex in Parkinson's disease. BMC Complement Altern Med 2014;14:336. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175221/. Accessed August 28, 2017. https://doi.org/10.1186/1472-6882-14-336
  34. Shim JS, Kim HG, Ju MS, Choi JG, Jeong SY, Oh MS. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease. J Ethnopharmacol 2009;126(2):361-5. https://doi.org/10.1016/j.jep.2009.08.023
  35. Sasaki-Hamada S, Suzuki A, Ueda Y, Matsumoto K, Oka JI. Serotonergic and dopaminergic systems are implicated in antidepressant-like effects of chotosan, a Kampo formula, in mice. J Pharmacol Sci 2017;133(2):110-3. https://doi.org/10.1016/j.jphs.2017.01.002
  36. Kim ST, Moon W, Chae Y, Kim YJ, Lee H, Park HJ. The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-in duced proteomic changes in the mouse striatum. J Physiol Sci JPS 2010;60(1):27-34. https://doi.org/10.1007/s12576-009-0061-7
  37. Leo RJ, Lichter DG, Hershey LA. Parkinsonism associated with fluoxetine and cimetidine: a case report. J Geriatr Psychiatry Neurol 1995;8(4):231-3. https://doi.org/10.1177/089198879500800406

Cited by

  1. Acupuncture Treatment in Clinical Studies for Parkinson's Disease : A Literature Review vol.35, pp.4, 2017, https://doi.org/10.13045/jar.2018.00157
  2. Risperidone으로 유발된 것으로 의심된 약물유발성 이상운동증에 대한 의심약물 중단 및 억간산가진피반하와 GB34(陽陵泉) 전침치료를 통한 외래기반 관리 : 증례보고 vol.40, pp.6, 2017, https://doi.org/10.22246/jikm.2019.40.6.1303